ASTRAZENECA PLC DL-,25/ GB0009895292 /
25/06/2024 13:18:07 | Chg. +1.10 | Volume | Bid18:14:43 | Ask18:14:43 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
148.50EUR | +0.75% | 75 Turnover: 11,125 |
148.50Bid Size: 20 | 149.20Ask Size: 20 | 229.83 bill.EUR | - | - |
GlobeNewswire
18/06
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire
18/06
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire
13/06
Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire
08/05
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
06/05
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
02/05
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
28/03
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...